Philippos Costa

14PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCancer geneticsSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 16, 2026
Liposomal Versus Conventional Doxorubicin as First-Line Therapy in Advanced Soft Tissue Sarcomas: Observational Multi-Institutional Cohort of 8.5-Year Experience.

|Aug 01, 2025
PALB2 c.3106G>C (p.Val1036Leu) in a familial cancer setting suggesting potential pathogenicity.

Philippos Apolinario Costa, Nicole Hardy, Patricia LoRusso

|Jan 13, 2025
Enhancing rare cancer care in developing countries through patient advocacy: insights from the Desmoid Tumor Brazilian Association.

Philippos Apolinario Costa, Carolina Menezes, Bruna Bianca Lopes David

|Nov 15, 2024
Sorafenib or anthracycline-based chemotherapy for progressive desmoid tumors.

Philippos Apolinario Costa, Arshia Arora, Yannelys Fernandez

|Jan 16, 2024
Neoadjuvant Intra-arterial Cytoreductive Chemotherapy Improves Outcomes in Lacrimal Gland Adenoid Cystic Carcinoma.

Philippos Apolinario Costa, David T Tse, Pasquale Benedetto

|Sep 03, 2022
Acute pancreatitis from a delayed haemolytic transfusion reaction.

Crystal Lihong Yan, Philippos Apolinario Costa, YanYun Wu

Pageof 3

Frequent Collaborators

3 joint publications

Andrea P Espejo-Freire

2 joint publications

Jonathan C Trent

2 joint publications

Irvin Yi

2 joint publications

Nicole Hardy